comparemela.com

Latest Breaking News On - Medical treatments - Page 7 : comparemela.com

Biogen halts development of controversial Alzheimer's drug

Biogen is halting the development and commercialization of the Alzheimer's drug Aduhelm, which drew intense scrutiny of its U.S. regulatory process due to.

Drug-administration
Biogen-inc
Article-normal
Biotechnology
Pharmaceuticals
Machinery
Agricultural-machinery
Banking
Commercial-banking
Healthcare-life-sciences
Banking-credit

GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales -- Update

By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the.

United-kingdom
British
Joe-hoppe
Visible-alpha
Article-normal
Pharmaceuticals
Vaccines
Healthcare-life-sciences
Specialized-drugs-medications
Financial-performance
Earnings

vimarsana © 2020. All Rights Reserved.